HOME

ABOUT GENTA

Overview

Management Team

Board of Directors

PRODUCTS

Ganite^®

PIPELINE

Overview

Tesetaxel

Genasense^®

Oral Gallium

INVESTOR RELATIONS

Overview

Press Releases

SEC Filings

Investor Relations Kit

Events Calendar

Corporate Governance

CAREERS

Overview

Commitment to Diversity

Benefits

To contact Genta Investor Relations, please send your inquiries via email to info@genta.com

Investor Relations Kit

We invite you to create your own investor kit with the documents provided below. You will find the most recent Genta Incorporated 10-K report and 10-Q report.

Genta Form 10-K: December 31, 2008
Genta Form 10-Q: September 10, 2009
Genta Corporate Factsheet

Coming Events

12th Annual BIO CEO & Investor Conference
February 8-9, 2010
New York, NY

SEC Filings

Section 16 Filings (3, 4, 5,) for Directors and Executive Officers.

PIPELINE

	Overview

	Tesetaxel - Mechanism of Action - Preclinical Data - Publications - Clinical Development

	Genasense^® - Antisense Technology - Mechanism of Action - Preclinical - Clinical Development - Information for Patients

	Oral Gallium - Mechanism of Action - Preclinical - Publications - Clinical Development

ABOUT GENTA

PRODUCTS

PIPELINE

INVESTOR RELATIONS

CAREERS

Investor Relations Kit